Neuroprotective effect of pleiotrophin on dopaminergic neurons in vitro and in vivo

被引：0
|
作者：
Watanabe, Yoko [1 ,2 ]
Misumi, Sachiyo [1 ]
Masuda, Tadashi [1 ]
Matsunaga, Tamihide [2 ]
Suzuki, Tadashi [2 ]
Hida, Hideki [1 ]
机构：
[1] Nagoya City Univ, Dept Neurophysiol & Brain Sci, Nagoya, Aichi, Japan
[2] Nagoya City Univ, Educ Res Cntr Clin Phar, Nagoya, Aichi, Japan
来源：
NEUROSCIENCE RESEARCH | 2010年 / 68卷
关键词：
D O I：
10.1016/j.neures.2010.07.2207
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：E143 / E143
页数：1
相关论文
共 50 条
  • [31] Neuroprotective effect of retinoid receptor agonist Am80 on dopaminergic neurodegeneration in vivo
    Takemori, Sachiko
    Kimura, Shigeru
    Hisatsune, Akinori
    Isohama, Yoishiro
    Katsuki, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 257P - 257P
  • [32] Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons
    Borlongan, CV
    Su, TP
    Wang, Y
    NEUROREPORT, 2000, 11 (05) : 923 - 926
  • [33] Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies
    Xu, L
    Sheng, JS
    Tang, ZS
    Wu, XF
    Yu, Y
    Guo, H
    Shen, Y
    Zhou, CF
    Paraoan, L
    Zhou, JW
    NEUROBIOLOGY OF DISEASE, 2005, 18 (01) : 152 - 165
  • [34] HLDF-6 hexapeptide neuroprotective effect on rat hippocampal neurons at the Alzheimer's disease model in vivo and in vitro
    Lipkin, V. M.
    Zhokhov, S. S.
    Storozheva, Z. I.
    Proshin, A. T.
    Surina, E. A.
    Babichenko, I. I.
    Kostanyan, I. A.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 95 - 95
  • [35] Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of alzheimer’s disease
    I. A. Kostanyan
    S. S. Zhokhov
    Z. I. Storozheva
    A. T. Proshin
    E. A. Surina
    I. I. Babichenko
    V. V. Sherstnev
    V. M. Lipkin
    Russian Journal of Bioorganic Chemistry, 2006, 32 : 360 - 367
  • [36] Neuroprotective effect of the hexapeptide HLDF-6 on rat hippocampal neurons on the in vivo and in vitro models of Alzheimer's disease
    Kostanyan, I. A.
    Zhokhov, S. S.
    Storozheva, Z. I.
    Proshin, A. T.
    Surina, E. A.
    Babichenko, I. I.
    Sherstnev, V. V.
    Lipkin, V. M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2006, 32 (04) : 360 - 367
  • [37] Evaluate the in vitro effect of anthracycline and alkylating cytophosphane chemotherapeutics on dopaminergic neurons
    Desai, Darshini
    Majrashi, Mohammed
    Pathak, Suhrud
    Almaghrabi, Mohammed
    Liu, Keyi
    Pondugula, Satyanarayana R.
    Tiwari, Amit K.
    Babu, R. Jayachandra
    Deruiter, Jack
    Dhanasekaran, Muralikrishnan
    CANCER REPORTS, 2024, 7 (04)
  • [38] In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons
    Fasciani, Irene
    Petragnano, Francesco
    Bono, Federica
    Aloisi, Gabriella
    Mutti, Veronica
    Pardini, Carla
    Carli, Marco
    Scarselli, Marco
    Vaglini, Francesca
    Angelucci, Adriano
    Fiorentini, Chiara
    Lozzi, Luca
    Missale, Cristina
    Maggio, Roberto
    Rossi, Mario
    NEUROSCIENCE, 2024, 544 : 104 - 116
  • [39] Can the developing striatum effect the dopaminergic features of hNT neurons in vitro?
    Misiuta, I
    McGrogan, M
    Willing, A
    Sanberg, P
    Zigova, T
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 18 - 18
  • [40] Neuroprotective effect of human mesenchymal stem cell on dopaminergic neurons by anti-inflammatory action
    Lee, P. H.
    Kim, Y.-J.
    Park, H.-J.
    Yong, S. W.
    MOVEMENT DISORDERS, 2007, 22 : S23 - S23
12345